Meiji Seika Pharma Aims to Increase No. of MRs to 900 as Soon as Possible

Masahiko Matsuo, President and Representative Director, Meiji Seika Pharma In its briefing on a new three-year midterm business plan for FY2012 to FY2014 held on May 24, Masahiko Matsuo, president and representative director of Meiji Seika Pharma, revealed that the...read more